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Circuit-based interrogation of  
sleep control
Franz weber1 & Yang Dan1
S leep is a seemingly unproductive behavioural state that takes up a large proportion of our lives, but insufficient sleep can profoundly impair our cognitive performance during wakefulness. Long-term 
sleep deprivation is also linked to many other health problems, including 
obesity and cardiovascular diseases. At the behavioural level, sleep has 
been observed widely across the animal kingdom, including in worms 
and flies, as well as vertebrates. However, the existence of two distinct 
types of sleep—rapid eye movement (REM) sleep and non-REM (NREM) 
sleep—was previously thought to be restricted to mammals and birds and 
has only recently been identified in reptiles1.
Wakefulness, NREM sleep and REM sleep can be clearly distinguished 
based on electroencephalogram (EEG) and electromyogram (EMG) 
recordings, making sleep a directly quantifiable behaviour. During wake-
fulness, the EEG exhibits high-frequency, low-amplitude activity (‘desyn-
chronized EEG’), and the EMG shows high muscle tone (Fig. 1a, c). In 
contrast, the EEG during NREM sleep is dominated by high-amplitude, 
low-frequency (0.5–4.5 Hz) activity (‘synchronized EEG’) together with 
sleep spindles (waxing and waning of 9–15 Hz oscillations lasting for a 
few seconds). REM sleep is associated with vivid dreaming; it is also called 
paradoxical sleep, as it is characterized by desynchronized EEG resem-
bling that during wakefulness, but the EMG shows a complete paralysis of 
postural muscles2. The proportions of time the animal spends in wakeful, 
NREM and REM states and the temporal patterns of state transitions vary 
widely across species3 (Fig. 1b, d). However, there are some well- 
conserved features. For example, animals normally enter REM sleep from 
NREM sleep but not directly from wakefulness.
Up until the 20th century, sleep was believed to be a passive process, 
caused by reduced sensory stimulation that allows our normal mental 
and physical activities to shut down. We now know, however, that both 
NREM and REM sleep are controlled by distinct neural circuits in the 
brain, the malfunction of which causes a variety of sleep disorders. Since 
the discovery of the ascending reticular activating system more than half 
a century ago4, we have learned a great deal about the neural circuits 
supporting wakefulness5,6. In contrast, the neural mechanisms gener-
ating sleep have been far more elusive. While studies based on lesion, 
electrical stimulation and pharmacological manipulations (Fig. 2a, b) 
have implicated multiple brain regions that are important for sleep5,6, 
which neurons are responsible for triggering and maintaining NREM 
or REM sleep and how they are connected to each other remain largely 
unknown. A main difficulty resides in the fact that the sleep-promoting 
neurons are often spatially intermingled with, but outnumbered by, 
wake-promoting neurons, making it difficult to target them selectively 
for circuit analysis.
Over the past decade, several new techniques have become widely 
available, including optogenetics7, pharmacogenetics8, imaging with 
Sleep is a fundamental biological process observed widely in the animal kingdom, but the neural circuits generating 
sleep remain poorly understood. Understanding the brain mechanisms controlling sleep requires the identification 
of key neurons in the control circuits and mapping of their synaptic connections. Technical innovations over the past 
decade have greatly facilitated dissection of the sleep circuits. This has set the stage for understanding how a variety of 
environmental and physiological factors influence sleep. The ability to initiate and terminate sleep on command will also 
help us to elucidate its functions within and beyond the brain.
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Figure 1 | Sleep in humans and mice. a, Examples of a human 
electroencephalogram (EEG) and electromyogram (EMG) recordings 
during wakefulness, NREM sleep (stage 3) and REM sleep. b, Colour-
coded brain states (hypnogram) during a continuous 22-h recording from 
a healthy human subject. The EEG recordings (a) and hypnogram (b) 
are from the Sleep EDF database141,142. In humans, sleep is consolidated 
with rare awakenings during the night. REM sleep occurs regularly every 
~90 min. c, Example EEG and EMG recordings from a mouse during 
wakefulness, NREM and REM sleep. d, Hypnogram during a continuous 
24 h recording from a mouse in a dark–light cycle. Mice sleep more during 
the light cycle. Compared to humans, mice exhibit fragmented sleep 
patterns, characterized by short sleep bouts and frequent awakenings.  
e, A 2 h segment from the hypnogram in d shown at an expanded scale.  
In mice, REM sleep occurs every 10 to 20 min.
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genetically encoded calcium indicators9 and virus-mediated circuit trac-
ing10,11 (Figs 2 and 3). Combined with mouse genetics, these techniques 
endow us with an unprecedented capability for measuring and controlling 
the activity of specific cell types and dissecting their synaptic connections, 
greatly facilitating our investigation of the mechanisms that control sleep. 
In this review, we focus on the neural circuits controlling both NREM and 
REM sleep in the mammalian brain, with a particular emphasis on studies 
enabled by recently developed technologies. The function and genetics 
of sleep and studies in non-mammalian species are not covered here, but 
can be found in several recent reviews12–16.
Forebrain control of sleep versus wakefulness
Multiple brain areas have been implicated in controlling the switch 
between wakefulness and the general state of sleep, including both REM 
and NREM sleep. Many of these areas are located in the forebrain, includ-
ing the preoptic hypothalamus, basal forebrain and lateral hypothalamus.
Preoptic hypothalamus
The preoptic area (POA) of the anterior hypothalamus has long been 
known to be important for sleep generation. In the 1920s, Von Economo 
found that damage to the POA was associated with insomnia in human 
patients17. By systematically varying the location of a brain lesion in the 
rat, Nauta concluded that the POA is a ‘sleep center’18, a notion that was 
supported by subsequent lesion19,20 and muscimol injection21 experi-
ments in the cat. In the 1990s and 2000s, c-Fos immunohistochemistry 
following sustained sleep revealed sleep-active GABAergic neurons in 
the ventrolateral preoptic area (VLPO) and the median preoptic nucleus 
(MnPO)22,23, and selective lesion of the VLPO drastically reduced NREM 
sleep24. A recent study showed that pharmacogenetic activation of the 
c-Fos-labelled neurons in the POA induces sleep, further supporting their 
causal role in sleep regulation25.
Neurons in the VLPO and MnPO are likely to promote sleep through 
their inhibitory projections to wake-promoting brain areas (Fig. 4). 
Targets of these projections include the major wake-promoting mono-
aminergic centres such as the histaminergic tuberomammillary nucleus 
(TMN), serotonergic dorsal and median raphe nuclei (DRN and MRN) 
and noradrenergic locus coeruleus (LC)26,27. They also project to the 
perifornical lateral hypothalamus28, which contains the wake-promoting 
orexin (also known as hypocretin) neurons29, the ventral periaque-
ductal grey matter (vPAG)30 and the parabrachial nucleus26, which 
has also been shown to be important for wakefulness and arousal31. 
Among these targets, the POA projection to the TMN in the posterior 
hypothalamus appears particularly strong26,27,32 and may powerfully 
inhibit TMN neurons during sleep33. The importance of this projec-
tion is supported by the observation that inactivating the posterior 
hypothalamus with muscimol injection can strongly promote sleep21 
and can reverse the insomnia induced by a POA lesion20. Microdialysis 
measurements showed that the extracellular concentrations of GABA 
in the LC and DRN also increase during sleep and that GABA levels are 
highest during REM sleep34,35, when these monoaminergic neurons are 
virtually silent36. This shows the importance of GABAergic inputs in 
regulating the firing of these neurons across brain states, and it is prob-
able that POA sleep-active neurons provide a substantial source of such 
GABAergic inputs. In addition to GABA, the neuropeptide galanin is 
also expressed in, and presumably released by, many POA sleep-active 
neurons26,27,32, which can inhibit the TMN histaminergic neurons37 and 
noradrenergic neurons of the LC38.
What inputs activate the POA neurons during sleep and/or suppress 
them during wakefulness? Anatomically, histaminergic, noradrenergic 
and serotonergic axon fibres are observed in the POA39. In vitro record-
ings showed that ~70% of VLPO neurons are inhibited by noradrenaline 
and acetylcholine, with a subset also inhibited by serotonin40. Although 
histamine does not directly inhibit VLPO neurons, it might activate 
noradrenaline-excited interneurons, which could in turn inhibit the 
sleep neurons41. These effects of the wake-promoting neuromodulators 
probably suppress the activity of POA sleep neurons during wakefulness. 
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Figure 2 | Methods for neuronal manipulations. a, Various techniques 
grouped depending on whether they are cell-type-specific (orange box) 
or non-specific (grey box). Circle indicates timescale of each method. 
Text colour depicts activation versus suppression of neural activity 
(red and blue; gain and loss of function, respectively). Non-cell-type-
specific methods include electrical stimulation of neurons or fibre 
tracts, pharmacological application of agonists or antagonists to specific 
receptors, and various methods for lesions. Using optogenetics, the light-
activated cation-channel channelrhodopsin (ChR2) can be expressed 
in genetically defined cell types, allowing for their activation by light 
within milliseconds7. By contrast, light activation of the chloride pumps 
halorhodopsin (NpHR) or archaerhodopsin (Arch) causes rapid neural 
inhibition. Recently, a light-activated chloride channel (iC++) was 
developed143. Using pharamacogenetics, neurons can be continuously 
activated or inhibited for hours. The method relies on an extrinsic G 
protein-coupled muscarinic receptor, of which an excitatory (hM3Dq) 
and an inhibitory (hM4Di) version exist. The receptor is activated only 
by a physiologically inert, synthetic ligand8. Lesions of specific cell types 
can be achieved using genetically encoded toxins (diphtheria toxin)144 or 
apoptotic signalling molecules (caspase 3)145. b, Lesion of the POA and BF 
in cats induced long-lasting inhibition of sleep (d, days; w, weeks). Right, 
schematic depicting the lesioned region. Data reprinted and adapted with 
permission from ref. 19. c, Millisecond precision of neural manipulation 
afforded by optogenetics allowed a closed-loop stimulation protocol 
to test the role of GABAergic ventral medulla neurons in REM sleep 
maintenance. The laser was turned on after spontaneous REM onset and 
turned off at the end of the REM episode. Data adapted from ref. 74.
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Histaminergic neurons could also inhibit the sleep neurons through their 
co-release of GABA42. In addition, sleep-active POA neurons express κ 
and μ opioid receptors43, both of which can activate potassium channels 
and inhibit voltage-gated calcium channels, thereby reducing the excit-
ability of the neurons. However, while local application of a μ receptor 
agonist within the VLPO promotes wakefulness, a κ receptor agonist 
promotes NREM sleep, suggesting the existence of other sites of action 
besides the sleep-active neurons. Retrograde tracing combined with 
in situ hybridization suggests that neurons in the TMN release endo-
morphin (a μ receptor agonist), whereas those in the lateral parabrachial 
nucleus release dynorphin (a κ receptor agonist). Notably, dynorphin is 
also expressed within the POA, raising the possibility of a local source 
for promoting sleep.
Whereas inputs from wake-promoting neurons are generally inhibitory, 
VLPO neurons were recently shown to be excited by physiological con-
centrations of glucose and might thus mediate the sleep-promoting effect 
of glucose infusion into the VLPO44. This is opposite to the wake- 
promoting orexin neurons, which are inhibited by high sucrose levels45. 
Thus, the activity of both wake- and sleep-promoting neurons might be 
sensitive to the energy status of the animal, which may explain why we 
feel sleepy after eating a meal that is high in sugar. Moreover, the POA 
contains thermosensitive neurons that are activated by either warming or 
cooling of the POA within a physiologically relevant temperature range46. 
Notably, the majority of warm-sensitive neurons are also sleep-active47, 
which may provide a mechanistic link between the control of sleep and 
body temperature. An important direction for future studies is to identify 
additional inputs to the POA sleep-promoting neurons that allow inte-
gration of temperature, energy status and other physiological variables 
for the optimal control of sleep.
The studies summarized above have provided important insights 
into how the POA contributes to sleep regulation. However, single-unit 
recordings and c-Fos staining indicate that the sleep-active neurons are 
not restricted to the VLPO or MnPO, and even within these regions they 
are spatially intermingled with wake-active neurons, many of which 
are also GABAergic48–50. Although galanin is expressed in many VLPO 
sleep-active neurons26,27,32, it also labels the nearby medial preoptic 
nucleus, which is involved in parental behaviours51. A crucial step in 
dissecting the POA sleep circuit is to identify molecular markers that 
specifically label sleep-active and sleep-promoting neurons to allow selec-
tive manipulation, recording and input and output tracing from these 
neurons.
Basal forebrain
While the sleep-promoting POA neurons appear to inhibit wake- 
promoting circuits in multiple regions of the brain, recent work in the 
basal forebrain (BF, adjacent to the POA) showed that sleep neurons can 
also suppress wake-promoting neurons locally. Lesion studies have sug-
gested that the BF is important for both sleep and wakefulness19,31,52, and 
it contains spatially intermingled sleep- and wake-active neurons49,53,54.
There are three major cell types in the BF: cholinergic, glutamatergic 
and GABAergic. Juxtacellular recording and labelling in head-fixed rats 
followed by immunohistochemical staining showed that the cholinergic 
neurons are wake- and REM-active55, and that optogenetic activation 
of these neurons promotes wakefulness56,57. Cell-type-specific channel-
rhodopsin (ChR2) tagging and optrode recording in freely moving mice 
showed that glutamatergic and parvalbumin (PV)-expressing GABAergic 
neurons are also wake- and REM-active, and that activation of these neu-
rons promotes wakefulness. In contrast, a subpopulation of somatostatin 
(SOM)-expressing GABAergic neurons are NREM-active and activation 
of this SOM population promotes NREM sleep57.
The intermingling of multiple cell types in the BF provides ample 
opportunity for local synaptic interactions, which have been analysed 
by ultrastructural studies58, in vitro pharmacology59 and in vivo micro-
dialysis60. Indeed, ChR2-assisted circuit mapping in BF slices revealed 
functional synapses for most pairs of cell types57 (Fig. 4c). In particu-
lar, SOM GABAergic neurons provide strong inhibition to cholinergic, 
glutamatergic, and PV-expressing GABAergic neurons, all of which are 
wake-promoting. Thus, broad inhibition of multiple wake-promoting cell 
types, via either local synapses57 or long-range projections22,26, appears to 
be a common feature of sleep-promoting GABAergic neurons13 (Fig. 4). 
The local glutamatergic → cholinergic, glutamatergic → PV-expressing, 
and cholinergic → PV-expressing neuron excitation detected in these 
experiments also provides useful insights into the inputs that shape the 
wake- and REM-active properties of these BF neurons and the local cir-
cuits that are recruited when a given cell type (for example, glutamatergic) 
is activated optogenetically.
Lateral hypothalamus
Similar to the POA and BF, the lateral hypothalamus also contains inter-
mingled sleep- and wake-active neurons, with a subset of the sleep-active 
neurons expressing melanin-concentrating hormone (MCH)61,62. A study 
based on juxtacellular recordings showed that MCH neurons are sleep- 
active, with maximal firing rates during REM sleep63. Brief optogenetic 
activation of MCH neurons (tens of seconds per trial) increased the tran-
sitions from NREM to REM sleep64 and prolonged the durations of REM 
sleep episodes62, indicating that MCH neuron activation enhanced both 
the initiation and maintenance of REM sleep. However, archaerhodopsin 
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Figure 3 | Methods for measuring neural activity. a, c-Fos 
immunohistochemistry is widely used to detect sleep-active neurons. 
Following spontaneous sleep or deprivation-induced sleep rebound, brain 
tissue is stained for the expression of the immediate early gene c-Fos, used 
as a marker for neuronal activation. Right, brain section showing c-Fos-
positive cells (black) in the parafacial zone (PZ; 7N, facial nucleus; scale 
bar, 300 μm). Data reprinted with permission from ref. 76. b, Recording 
from genetically defined cell types using optogenetic tagging. Left, 
recording with optrodes (microelectrodes coupled with an optic fibre) 
allows the experimenter to test whether a recorded unit is reliably driven 
by laser stimulation and thus can be classified as the ChR2-expressing 
cell type. Right, example recording of a REM-active GAD2-neuron in the 
ventral medulla along with colour-coded brain states. Data adapted from 
ref. 74. c, Calcium imaging from identified cell types. Top left, using a 
microendoscope coupled to a head-mountable miniaturized camera, the 
calcium responses of identified cell types can be imaged in deep brain 
structures of freely moving mice. Bottom left, GAD2 neurons in the dorsal 
pons expressing the genetically encoded calcium indicator GCaMP6. 
Right, calcium (ΔF/F) transients of five wake-active neurons (red circles 
in bottom left picture) along with colour-coded brain states. Data adapted 
from ref. 85.
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(Arch)- or halorhodopsin (NpHR)-mediated silencing of these neurons 
caused no pronounced change in the amount or duration of REM 
sleep62,64, suggesting that MCH neuron activity is sufficient but perhaps 
not necessary. Notably, selective ablation of MCH neurons using cell-
type-specific expression of diphtheria toxin A caused a decrease of NREM 
sleep without affecting REM sleep64, suggesting that chronic activity of 
these neurons is important for NREM sleep. This notion is also supported 
by the finding that chronic optogenetic activation of MCH neurons (24 h) 
can enhance NREM as well as REM sleep65.
The sleep-promoting effect of MCH neurons could be mediated in 
part by their inhibitory influence on nearby orexin neurons66, which 
promote wakefulness29 and indirectly inhibit MCH neurons67 (Fig. 4d). 
Optogenetic activation of MCH neurons also induces inhibitory post-
synaptic currents in histaminergic and other neurons in the lateral and 
posterior hypothalamus, a pathway that is thought to be important for the 
in vivo effect62. Notably, these inhibitory responses are primarily caused 
by GABA rather than MCH synaptic transmission, consistent with the 
finding that MCH neuron activation can promote REM sleep even in the 
absence of MCH receptors62.
Control of NREM versus REM sleep
After suppression of wakefulness by forebrain sleep neurons, the brain 
alternates between NREM and REM sleep. The duration of the so-called 
ultradian NREM/REM cycle varies across species; 90–120 min in humans 
(Fig. 1b) and 10–20 min in rodents (Fig. 1d, e). Following the discovery of 
REM sleep and its associated dreaming in the 1950s2,68, the neural mech-
anisms controlling this brain state have been under active investigation.
By making surgical transections at various rostrocaudal levels of the 
cat brain and measuring the neural signatures of REM sleep on each side 
of the cut, Jouvet concluded that the brainstem is both necessary and 
sufficient for REM sleep generation68. Two prominent neuromodulatory 
systems show opposite firing rate changes at NREM to REM transitions: 
monoaminergic neurons cease to fire (REM off) and cholinergic neurons 
become highly active (REM on)36. This led to the formulation of a model 
for the ultradian cycle based on the reciprocal interactions between these 
two neuronal populations36,69. Subsequent studies, however, have pointed 
to more prominent roles of glutamatergic and GABAergic neurons in 
REM sleep generation70–74 (Fig. 5a). Furthermore, recent studies have 
identified several groups of glutamatergic and GABAergic brainstem 
neurons that specifically promote NREM sleep71,74–76 (Fig. 5b). The 
antagonistic interactions between these REM- and NREM-promoting 
neurons within the brainstem may play important roles in controlling 
the ultradian cycle.
REM-promoting neurons in the brainstem
Following Jouvet’s landmark transection studies68, lesion and pharma-
cological experiments have consistently identified the dorsolateral pons 
as an important region for REM sleep generation5,72,77,78. This region 
contains diverse cell types, including cholinergic, noradrenergic, gluta-
matergic and GABAergic neurons, and their respective functions in REM 
sleep control are still under debate5,36,70,72.
Cholinergic neurons in the pedunculopontine tegmentum (PPT) and 
laterodorsal tegmentum (LDT) are wake- and REM-active neurons79. 
Early pharmacological experiments showed a powerful effect of cholin-
ergic agonists in REM sleep generation, but application of antagonists 
or lesions of cholinergic neurons have yielded variable results5,72,80,81. In 
a recent study, the role of pontine cholinergic neurons was tested using 
optogenetics82. Activation of these neurons during NREM sleep increased 
the frequency but not the duration of REM sleep episodes, suggesting 
that these neurons contribute to REM sleep initiation but perhaps not 
to maintenance.
Extracellular recordings in the cat suggested that there are also 
non-cholinergic REM-on neurons in the dorsal pons83. Using c-Fos 
immunohistochemistry to detect REM-active cells, some investiga-
tors identified glutamatergic neurons in the sublateral dorsal nucleus 
(SLD)70,72, while others also found GABAergic neurons in the region72,84. 
Juxtacellular recordings in head-fixed rats confirmed the existence of 
REM-active GABAergic neurons79, and cell-type-specific calcium imag-
ing in freely moving mice revealed REM-active glutamatergic neurons85. 
Pharmacological activation of the SLD induced a REM sleep-like state 
with EEG desynchronization and muscle atonia77, and conditional 
knockout of Vglut2 (the gene encoding vesicular glutamate transporter 
2) caused fragmentation of REM sleep and reduced its amount86, indi-
cating an important role of SLD glutamatergic neurons in REM sleep 
generation.
In addition to the pons, c-Fos immunohistochemistry showed that the 
medulla also contains REM-active neurons73. While previous studies have 
emphasized the function of the ventral medulla in generating the muscle 
atonia associated with REM sleep through its projections to the spinal 
cord87,88, a recent study demonstrated that rostrally projecting ventral 
medulla neurons are critical in generating REM sleep74. Optogenetic 
activation of GABAergic neurons in the ventral medulla or their axons 
projecting to the midbrain induced a marked increase in the probability 
of NREM to REM transitions, but activating glutamatergic neurons in the 
same region reliably induced wakefulness, attesting to the importance of 
cell-type-specific manipulation of neuronal activity. Using a closed-loop 
stimulation protocol afforded by rapid optogenetic control of neuronal 
activity (Fig. 2c), activation or silencing of the GABAergic neurons was 
found to respectively prolong or shorten the duration of each REM sleep 
episode, indicating that the activity of these neurons is also important for 
maintaining REM sleep. Furthermore, optrode recording from ChR2-
tagged GABAergic neurons shows that their firing rates increase gradu-
ally over a period of tens of seconds before the onset of REM sleep and 
are sustained at a high level during each REM sleep episode, a temporal 
profile well suited for their roles in the induction and maintenance of 
REM sleep (Fig. 3b). Importantly, their natural firing rates during REM 
sleep are higher than the laser stimulation frequency necessary to induce 
REM sleep, indicating that their endogenous activity is sufficient for the 
REM-promoting effects demonstrated with optogenetic manipulations. In 
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Figure 4 | Circuit diagram for forebrain sleep-promoting mechanisms. 
a, Sleep-active neurons in the POA inhibit wake-active neurons in the 
lateral and posterior hypothalamus (LH and PH) and in the brainstem 
including the dorsal raphe nucleus (DRN), locus coeruleus (LC), 
ventral periaqueductal grey (vPAG), and parabrachial nucleus (PB). 
b, Sleep-active GABAergic (Gad) neurons in the POA are inhibited by 
norepinephrine (NE), acetylcholine (ACh) and a subgroup by serotonin 
(5-HT). c, Within the basal forebrain, somatostatin (SOM) neurons inhibit 
neighbouring wake-promoting glutamatergic (Glut), cholinergic (ChAT), 
and parvalbumin (PV)-expressing GABAergic neurons. Glutamatergic 
neurons powerfully promote wakefulness through excitation of ChAT and 
PV neurons. d, Sleep-active neurons in the POA inhibit wake-promoting 
histaminergic (HA) and orexin (also known as hypocretin) (Orx/Hcrt) 
neurons in the LH and PH. Sleep-active melanin-concentrating hormone 
(MCH)-expressing neurons suppress HA and Orx/Hcrt neurons. MCH 
and Orx/Hcrt neurons mutually inhibit each other. e, Sleep-active neurons 
in the POA inhibit wake-promoting neurons in the brainstem including 
NE-, dopamine (DA)-, 5-HT- and glutamate (Glut)-expressing neurons in 
the LC, vPAG, DRN, and PB.
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addition to spike rate, such cell-type-specific recordings in vivo may also 
reveal brain-state-dependent changes in firing pattern (for example, burst 
versus tonic), which may strongly influence the release of neuropeptides 
important for regulating brain states89.
NREM-promoting neurons in the brainstem
Early transection and pharmacological inactivation experiments pointed 
to a synchronizing mechanism in the medulla, which reduces the mag-
nitude and duration of EEG desynchronization induced by stimulating 
the ascending reticular activating system90. Subsequent studies showed 
that electrical stimulation of the nucleus of the solitary tract (NTS) syn-
chronized the EEG and increased sleep91. The finding of NREM-active 
neurons in the NTS92 further suggests the physiological relevance of this 
region, although the specific cell type that mediates the synchronizing 
effect remains unknown.
Recent studies have identified additional cell groups in the midbrain, 
pons and medulla that promote NREM sleep (Fig. 5b). Pharmacogenetic 
activation of a population of glutamatergic neurons in the dorsolateral 
pons, located ventromedial to the superior cerebellar peduncle (SCP), 
enhanced NREM sleep71. c-Fos immunohistochemistry showed that 
many GABAergic neurons in the parafacial zone (PZ, located in the rostral 
medulla lateral and dorsal to the facial nucleus) are sleep-active76. Lesion 
of PZ neurons or deletion of Vgat (the gene encoding vesicular GABA/
glycine transporter) in these neurons strongly increased wakefulness, 
whereas pharmacogenetic activation of VGAT-expressing PZ neurons 
increased NREM sleep75,76. This effect is thought to be mediated by inhi-
bition of glutamatergic neurons in the medial parabrachial nucleus, which 
are known to be important for wakefulness and arousal31. Furthermore, 
optogenetic74 or pharmacogenetic71 activation of GABAergic neurons 
in the ventrolateral periaqueductal grey (vlPAG) or the adjacent deep 
mesencephalic reticular nucleus (DpMe) substantially increased NREM 
sleep, thus revealing yet another brainstem neuronal population promot-
ing NREM sleep.
NREM/REM antagonism
Note that the hypothalamic and BF sleep neurons seem to promote 
NREM and/or REM sleep primarily by suppressing wakefulness (Fig. 4). 
In contrast, the brainstem sleep neurons discussed above also contribute 
to NREM/REM antagonism. For instance, pharmacogenetic activation of 
PZ GABAergic neurons75 or the glutamatergic neurons ventromedial to 
the SCP71 leads to a strong suppression of REM sleep whilst enhancing 
NREM sleep. Optogenetic74 or pharmacogenetic71 activation of vlPAG 
or DpMe GABAergic neurons also suppresses REM sleep in addition to 
wakefulness, consistent with previous lesion72 and pharmacological inac-
tivation73,93 experiments. Conversely, activation of the ventral medulla 
GABAergic neurons promotes REM sleep by greatly enhancing NREM 
to REM transitions74, thus effectively suppressing NREM sleep.
The circuit basis for the antagonistic relationship between NREM and 
REM sleep probably involves mutual inhibition between the NREM- and 
REM-promoting neurons. Gating of REM sleep by the vlPAG and DpMe 
could be mediated by their GABAergic innervation of the SLD72, while 
trans-synaptic retrograde tracing with a modified rabies virus11 revealed 
that vlPAG GABAergic neurons were directly inhibited by the ventral 
medulla74. Optogenetic activation of GABAergic axons of ventral medulla 
neurons within the vlPAG was sufficient to trigger and maintain REM 
sleep, suggesting that the inhibition of the vlPAG by the ventral medulla 
is an important mechanism promoting NREM to REM transitions. These 
inhibitory interactions between the NREM- and REM-promoting neu-
rons might form the core of the ultradian oscillator. Notably, the duration 
of the ultradian cycle appears to be correlated with brain size3. In future 
studies it would be important to understand the temporal dynamics of the 
neuronal interactions that determine the duration of NREM/REM cycles, 
and how these dynamic properties are related to brain size.
Besides the NREM-promoting neurons, REM neurons must also inter-
act with wake-promoting neurons. For example, GABAergic neurons in 
the ventral74,94 and dorsal95 medulla probably inhibit the wake-active, 
REM-off noradrenergic neurons in the LC, which may be important 
for the maintenance of REM sleep by delaying awakening. Spontaneous 
awakening in humans is most likely to occur at the end of a REM sleep 
episode, and rodents typically wake up after REM sleep rather than 
immediately transitioning back into NREM sleep. What processes favour 
REM to wake over REM to NREM transitions? Notably, although some 
wake-promoting neurons are silent during REM sleep (for example, mon-
oaminergic and orexinergic neurons), the majority of neurons within 
the dorsolateral pons are both wake- and REM-active79,85. In the basal 
forebrain, glutamatergic, cholinergic, and PV-expressing GABAergic 
neurons are also REM- and wake-active, but their activation promotes 
wakefulness57. Such activation of wake-promoting neurons during REM 
sleep might bias the transition into wake rather than NREM sleep at the 
end of each REM episode.
Homeostatic and circadian regulation of sleep
While the rapid transitions between wake, NREM and REM states are 
controlled by mutual inhibitory interactions among the neuronal groups 
promoting these states, sleep is also known to be regulated by homeo-
static and circadian processes on much slower timescales96. How these 
processes influence the sleep–wake network is only partially understood.
Sleep pressure and homeostasis
Homeostatic regulation refers to the fact that after prolonged wakefulness 
the animal tends to sleep for longer periods and/or at higher intensities. 
The increased sleep intensity is reflected by increased slow-wave activity 
(SWA, between 0.5 and 4.5 Hz) in the EEG, which decays gradually during 
the course of recovery sleep97. SWA thus serves as an excellent marker 
for sleep pressure. The homeostatic regulation of sleep is under genetic 
control98; a variety of genes have been shown to affect sleep homeostasis, 
some of which are also involved in the circadian regulation of sleep16.
More than a century ago, Ishimori and Pieron found that injection 
of the cerebrospinal fluid from a sleep-deprived dog into a normal one 
triggered sleep99,100, leading to the idea that sleep pressure exerts its 
impact through chemical factors (somnogens) that accumulate during 
wakefulness. In particular, adenosine has been studied extensively as a 
somnogen. The extracellular concentration of adenosine increases with 
the time spent awake and declines during recovery sleep in both the basal 
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Figure 5 | Brainstem circuits controlling REM and NREM sleep.  
a, Brainstem circuit promoting REM sleep, in which neuronal interactions 
characterized in recent studies are selectively highlighted. Glutamatergic 
(Glut) REM-promoting neurons in the SLD are probably inhibited by 
NREM-promoting GABAergic (Gad) vlPAG neurons. Activation of 
GABAergic ventral medulla (vM) neurons that innervate the vlPAG might 
thus disinhibit the SLD and therefore promote NREM to REM transitions. 
Neurons in the ventral and dorsal medulla probably inhibit noradrenergic 
neurons in the LC to maintain REM sleep and delay awakening. b, NREM-
promoting circuit in the brainstem. GABAergic neurons in the vlPAG, 
parafacial zone (PZ) and glutamatergic neurons located ventromedial to 
the superior cerebellar peduncle (SCP) promote NREM sleep and strongly 
suppress both wakefulness and REM sleep. GABAergic vlPAG neurons, 
probably excited by the glutamatergic NREM-promoting neurons close 
to the SCP, inhibit the SLD and thus suppress REM sleep. Inhibition of 
the nearby medial parabrachial nucleus (PB) by GABAergic PZ neurons 
suppresses wakefulness and promotes NREM sleep. Electrical stimulation 
of the nucleus of the solitary tract (NTS) also increases sleep, but the 
underlying cell types and synaptic interactions are unknown.
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forebrain101 and cortex102. One source of adenosine could be the BF, with 
its cholinergic neurons playing a particularly important role103. There is 
also strong evidence for the involvement of astrocytes in regulating the 
adenosine concentration104,105.
Adenosine regulates neuronal activity via two major classes of adeno-
sine receptors: the inhibitory A1 receptors that are distributed through-
out the brain and the excitatory A2A receptors that are mainly localized 
in the striatum, nucleus accumbens and the olfactory tubercle. In A2A 
receptor knockout mice, caffeine (an A1 and A2A receptor antagonist) 
failed to promote wakefulness106 and deprivation-induced NREM sleep 
rebound was reduced107. In vivo application of an A2A receptor agonist 
increased NREM sleep and enhanced c-Fos expression in the VLPO 
and MnPO108,109, whereas application of an antagonist in the VLPO 
attenuated sleep-deprivation-induced increases in the firing rates of 
sleep-active neurons110. In brain slices, VLPO neurons were shown to 
be activated directly or indirectly via A2A receptors111,112. By contrast, 
A1 receptors mediate the inhibitory effect of adenosine on wake-active 
neurons in vitro, including basal forebrain cholinergic neurons113 and 
hypothalamic orexin neurons114. In vivo application of adenosine or A1 
receptor agonists also increased NREM sleep115. Although A1 receptor 
knockout mice showed no change in the homeostatic regulation of the 
amount of sleep116, conditional deletion of A1 receptors in the forebrain 
and brainstem attenuated the rebound in SWA induced by sleep depri-
vation104,117. Thus, adenosine seems to promote sleep by simultaneously 
activating sleep neurons through A2A receptors and suppressing wake 
neurons through A1 receptors.
Besides adenosine, other somnogenic factors have been identified, 
including prostaglandin D2, nitric oxide, growth hormone releasing hor-
mone and cytokines (for review see ref. 118). In particular, prostaglandin 
D2 has been shown to be a powerful somnogen. Injection of prostaglan-
din D2 into the POA or the nearby subarachnoid space increases sleep 
and c-Fos expression in the VLPO119, an effect that is probably mediated 
via the activation of prostaglandin receptors that in turn increase aden-
osine levels120.
In addition to acting on the hypothalamic and basal forebrain neurons 
that control global brain states, sleep homeostasis has a strong local com-
ponent. Cortical regions that have been more active during the preceding 
wake period exhibit stronger SWA during sleep121,122, which requires a 
local mechanism for measuring recent activity and synchronizing the 
cortical population. Recently, a class of cortical interneurons express-
ing neuronal nitric oxide synthase (nNOS) has been proposed as a link 
between sleep pressure and cortical SWA123,124. Expression of c-Fos in 
nNOS neurons correlates with SWA and as these neurons have long-range 
intracortical projections, nNOS neurons might therefore be well suited 
for synchronizing the activity of neural populations125.
While most of the studies on sleep pressure have focused on NREM 
sleep, REM sleep is also under strong homeostatic control126, which is 
probably separate from NREM sleep homeostasis127. The molecular and 
circuit mechanisms underlying REM sleep homeostasis represent an 
important frontier that remains largely unexplored.
Circadian rhythm of sleep
Circadian modulation of sleep depends critically on the suprachiasmatic 
nucleus (SCN) in the hypothalamus, the master pacemaker of the whole 
organism. Lesion of the SCN or its downstream target regions eliminates 
the daily rhythm of sleep without markedly affecting its amount128,129, 
suggesting that the SCN is not part of the core circuit for sleep generation, 
but it regulates the circadian timing of sleep.
SCN neuron spiking was shown to play a key role in regulating both 
the molecular clock and behavioural rhythm, as optogenetic activation 
or suppression of SCN activity was sufficient to alter the phase and peri-
odicity of clock gene expression and of the sleep–wake cycle130. The firing 
rates of SCN neurons are high during the subjective day and low dur-
ing the night, regardless of whether the animal is diurnal or nocturnal. 
Such circadian variation of electrical activity is controlled by both the 
molecular clock driven by multiple transcriptional/translational feedback 
loops131 that regulates the intrinsic excitability of SCN neurons132 and 
the synaptic inputs signalling the light–dark cycle of the environment133. 
Notably, in vivo multiunit recordings showed that, superimposed on the 
slow circadian variation, SCN neuron firing rates also change with the 
sleep–wake states on a timescale of seconds134. This is probably caused 
by synaptic inputs from neurons involved in sleep–wake regulation, such 
as cholinergic and monoaminergic neurons135,136. Given such ultradian 
firing rate modulations, it would be interesting to know whether SCN 
activity can exert rapid influences on brain states in the order of seconds 
to minutes, in addition to its well-known circadian effect in the order of 
hours. In addition, the SCN consists of multiple cell types including vas-
oactive intestinal peptide-positive and arginine vasopressin-positive cells. 
Whether different types of SCN neurons play distinct roles in sleep–wake 
regulation remains to be investigated.
The SCN projects to multiple target regions to coordinate a variety of 
physiological functions. Among these targets the dorsomedial hypotha-
lamic nucleus (DMH) may play a particularly important role in sleep–
wake regulation. Lesion of the DMH largely eliminated the sleep–wake 
circadian rhythm128. In addition, a study using a pseudo-rabies virus 
for trans-synaptic retrograde tracing showed that the DMH provides an 
important relay from the SCN to the LC137, which contains wake- 
promoting noradrenergic neurons138. Importantly, the DMH comprises 
both glutamatergic and GABAergic neurons that appear to innervate both 
sleep- and wake-promoting circuits128. Understanding the functional 
organization of this structure and how it mediates the circadian modu-
lation of sleep again requires cell-type-specific recording, manipulation 
and circuit mapping.
Looking forward
The past few years have witnessed rapid progress in our understanding 
of the neural circuits controlling sleep, largely enabled by technical inno-
vations that allow measurement and manipulation of neuronal activity 
from genetically defined cell types and tracing of their synaptic inputs 
and outputs. These new experimental approaches have led to the iden-
tification of additional neuronal populations in the hypothalamus, BF 
and brainstem that promote NREM and REM sleep, and their local and 
long-range connections are beginning to be delineated.
Of course, while these novel techniques have opened new avenues for 
investigation, it is always important to keep in mind their limitations. 
For example, while optogenetics provides an easily applicable method 
for controlling neural activity with cell-type specificity and high tem-
poral precision (Fig. 2), the results should be interpreted with care. In 
sleep–wake control circuits many neurons co-release neuropeptides 
and other modulators together with GABA or glutamate, but the release 
mechanisms show differential dependence on the rate and temporal 
pattern (for example, burst versus tonic) of spiking89. To assess whether 
the observed effects of optogenetic manipulations are physiological, it is 
important to measure the natural activity of the neurons across different 
behavioural states74,79,139. Combining optogenetic manipulations with 
microdialysis60 or with blockade of neurotransmitter/modulator recep-
tors using genetic or pharmacological approaches62 will also provide 
important insights into the downstream signalling pathways mediating 
the behavioural effects.
One of the most exciting developments in the past few years is the 
identification of new sleep-promoting neurons, and the growth of this 
list is likely to continue. An important question is whether these sleep- 
promoting cell groups are organized hierarchically, in recurrent loops, or 
whether they work in parallel to control different aspects of sleep. NREM 
and REM sleep alternate in an ultradian rhythm. Although we know a 
great deal about how transcriptional/translational feedback loops generate 
the circadian rhythm and how neuronal biophysical/synaptic properties 
underlie network oscillations on a millisecond–to–second timescale, we 
know very little about how the brain generates the ultradian REM–NREM 
alternation on a minute–to–hour time scale. The control of REM–NREM 
alternations probably depends on both the synaptic interactions among 
spiking neurons and slower translational/transcriptional processes and 
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accumulation of chemical substances. Uncovering these circuit and 
molecular mechanisms underlying the ultradian oscillation is not only 
important for sleep research, but will also bridge an important gap in our 
understanding of brain rhythms in general.
In addition to circadian and homeostatic regulations, sleep is strongly 
influenced by a variety of emotional and physiological parameters, such 
as stress, pain, hunger and body temperature. Some of the interactions 
between sleep and these other processes may be mediated by common 
neurons shared between different control circuits. For example, while 
MCH neuron activity contributes to sleep regulation62,64,65, the neuro-
peptide MCH has been implicated in feeding140; and while activation of 
ventral medulla GABAergic neurons during NREM sleep reliably induces 
REM sleep, it enhances eating during wakefulness74. Thus both hypotha-
lamic MCH neurons and ventral medulla GABAergic neurons may help 
to link the regulation of sleep and feeding. The regulation of sleep by 
the emotional, thermal and nutritional state of the animal probably also 
involves synaptic inputs from these circuits to the sleep–wake control net-
work. Furthermore, both sleep- and wake-promoting neurons are prob-
ably modulated by humoral factors such as stress hormones, cytokines 
and glucose. Identification of the corresponding receptors expressed in 
sleep and wake neurons will allow us to uncover the molecular basis for 
the interactions between the circuits controlling sleep and other biological 
functions that are essential for survival.
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